Insulin antibodies do not preclude optimization of metabolic control in women with IDDM during pregnancy

Diabetes Care

Volumn 19, Issue 9, 1996, Pages 979-982

  Dozio, Nicoletta ^a,b   Beretta, Angelo ^a   Castiglioni, Mariateresa ^a   Rosa, Susanna ^a   Scavini, Marina ^a   Belloni, Cristina ^a   Poloniato, Antonella ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HUMAN INSULIN; INSULIN ANTIBODY;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; DIABETES CONTROL; FEMALE; FIRST TRIMESTER PREGNANCY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; PREGNANCY COMPLICATION; SUBCUTANEOUS DRUG ADMINISTRATION; THIRD TRIMESTER PREGNANCY; WEIGHT GAIN;

EID: 0029776371     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.9.979     Document Type: Article

References (25)

1. Mann NP, Johnston DI, Reeves WG, Murphy MA: Human insulin and porcine insulin in the treatment of diabetic children: comparison of metabolic control and insulin antibody production. Br Med J 287: 1580-1582, 1983
2. Van Haeften TW, Heiling VJ, Gerich JE: Adverse effects of insulin antibodies on postprandial plasma glucose and insulin profiles in diabetic patients without immune insulin resistance. Diabetes Care 36: 305-309, 1987
3. Gray RS, Cowan P, Di Mario U, Elton RA, Clarke BF, Duncan LJP: Influence of insulin antibodies on pharmacokinetics and bioavailability of recombinant human and highly purified beef insulins in insulin dependent diabetics. Br Med J 290:1687-1691, 1985
4. Francis AJ, Hanning I, Alberti KGMM: The influence of insulin antibody levels on the plasma profiles and action of subcutaneously injected human and bovine short acting insulins. Diabetologia 28:330-334, 1985
5. Van Haeften TW, Krom BA, Gerich JE: Prolonged fasting hypoglycemia due to insulin antibodies in patient with non-insulin-dependent diabetes mellitus: effect of insulin withdrawal on insulin-antibody-binding kinetics. Diabetes Care 10: 160-163, 1987
6. Van Haeften TW, Bolli GB, Dimitriadis GD, Gottesman IS, Horwitz DL, Gerich JE: Effect of insulin antibodies and their kinetic characteristics on plasma free insulin dynamics in patients with diabetes mellitus. Metabolism 35:649-656, 1986
7. Van Haeften TW: Clinical significance of insulin antibodies in insulin-treated diabetic patients. Diabetes Care 12:641-648, 1989
8. Gardner DF, Wilson HK, Podet EJ, Arakaki RF, Nell LJ, Thomas JW, Crane MM, Field JB: Prolonged action of regular insulin in diabetic patients: lack of relationship to circulating insulin antibodies. J Clin Endocrinol Metab 62:621-627, 1986
9. Bistritzer T, Sack J, Theodor R, Weissglass L, Ben-Bassat I, Lahav M: Correlation between HbAlc, purified insulins, diabetic control and insulin antibodies in diabetic children. Horm Res 20:178-185, 1984
10. Vaughan NJA, Matthews JA, Kurtz AB, Nabarro JDN: The bioavailability of circulating antibody-bound insulin following insulin withdrawal in type I (insulin dependent) diabetes. Diabetologia 24:355-358, 1983
11. Jovanovic LG, Mills JL, Peterson CM: Anti-insulin antibody titers do not influence control or insulin requirements in early pregnancy. Diabetes Care 7:68-71, 1984
12. Coustan DR: Pregnancy in diabetic women. N Engl J Med 319:1663-1665, 1988
13. Freinkel N: Of pregnancy and progeny. Diabetes 29:1023-1035, 1980
14. Sodoyez JC, Koch M, Lemaire I, Sodoyez-Goffaux F, Rapaille A, François-Gérard CH, Sondag D: Influence of affinity of antibodies upon their detection by liquid phase radiobinding assay and solid phase enzyme linked immunosorbent assay: demonstration using monoclonal antibodies raised against rDNA human proinsulin. Diabetologia 34:463-468, 1991
15. Greenbaum CJ, Palmer JP: Insulin antibodies and insulin autoantibodies. Diabetic Med 8:97-105, 1991
16. Sodoyez-Goffaux F, Koch M, Dozio N, Brandenburg D, Sodoyez J-C: Advantages and pitfalls of radioimmune and enzyme linked immunosorbent assays of insulin antibodies. Diabetologia 31:694-702, 1988
17. Sodoyez JC, Sodoyez-Golfaux F: Effects of insulin antibodies on bioavailability of insulin: preliminary studies using 123-I-insulin in patients with insulin-dependent diabetes. Diabetologia 27:143-145, 1984
18. Dozio N, Sodoyez-Goffaux F, Koch M, Ziegler B, Sodoyez JC: Polymorphism of insulin antibodies in six patients with insulin-immune hypoglycaemic syndrome. Clin Exp Immunol 85:282-287, 1991
19. Sodoyez JC, Koch M, Sodoyez-Goffaux F: Anticorps anti-insuline: methodologie et implications clinique. Diabete & Metab 17:255-269, 1991
20. Krans HMJ, Porta M, Keen H: Diabetes care and research in Europe: the St. Vincent Declaration action programme. Implementation document. WHO Report, 1995, p. 30-32
21. Wredling R, Lins PE, Adamson U: Prevalence of anti-insulin antibodies and its relation to severe hypoglycaemia in insulin-treated diabetic patients. Stand J Clin Lab Invest 551-557, 1995
22. Cunnigham FG, Mac Donald PC, Gant UF (Eds.): Maternal adaptation to pregnancy. In Williams' Obstetrics. Norwalk, CT, ACC, 1993, p. 129-162
23. Menon RK, Cohen RM, Sperling MA, Cutfield WS, Mimouni F, Khoury JC: Transplacental passage of insulin in pregnant women with insulin-dependent diabetes mellitus: its role in fetal macrosomia. N Engl J Med 323:309-315, 1990
24. Jovanovic-Peterson L, Kitzmiller JL, Peterson CM: Randomized trial of human versus animal species insulin in diabetic pregnant women: improved glycemic control, not fewer antibodies to insulin, influence birth weight. Am J Obstet Gynecol 167:1325-1330, 1992
25. Heding LG, Persson B, Stangenberg M: B-cell function in newborn infants of diabetic mothers. Diabetologia 19:427-432, 1980